Добірка наукової літератури з теми "Cystic fibrosis Patients Victoria Nutrition"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Cystic fibrosis Patients Victoria Nutrition".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Cystic fibrosis Patients Victoria Nutrition"
Olson, Diane L., and W. Frederick Schwenk. "Nutrition for Patients With Cystic Fibrosis." Nutrition in Clinical Practice 19, no. 6 (December 2004): 575–80. http://dx.doi.org/10.1177/0115426504019006575.
Повний текст джерелаAllen, Elizabeth D., Anne B. Mick, Jennie Nicol, and Karen S. Mccoy. "Prolonged Parenteral Nutrition for Cystic Fibrosis Patients." Nutrition in Clinical Practice 10, no. 2 (April 1995): 73–79. http://dx.doi.org/10.1177/011542659501000273.
Повний текст джерелаRamirez, I., A. Filbrun, and S. Z. Nasr. "257 Improving nutrition for pediatric cystic fibrosis patients." Journal of Cystic Fibrosis 11 (June 2012): S122. http://dx.doi.org/10.1016/s1569-1993(12)60426-3.
Повний текст джерелаKusuma Yana, I. Gusti Agung Ari. "Cystic Fibrosis: Review." Jurnal Sains dan Kesehatan 3, no. 1 (February 28, 2021): 79–87. http://dx.doi.org/10.25026/jsk.v3i1.231.
Повний текст джерелаBrownell, Jefferson N., Hillary Bashaw, and Virginia A. Stallings. "Growth and Nutrition in Cystic Fibrosis." Seminars in Respiratory and Critical Care Medicine 40, no. 06 (October 28, 2019): 775–91. http://dx.doi.org/10.1055/s-0039-1696726.
Повний текст джерелаKalnins, Daina, Peter R. Durie, and Paul Pencharz. "Nutritional management of cystic fibrosis patients." Current Opinion in Clinical Nutrition and Metabolic Care 10, no. 3 (May 2007): 348–54. http://dx.doi.org/10.1097/mco.0b013e3280a94f80.
Повний текст джерелаWinklhofer-Roob, B. M. "Antioxidant status in cystic fibrosis patients." American Journal of Clinical Nutrition 63, no. 1 (January 1, 1996): 138–39. http://dx.doi.org/10.1093/ajcn/63.1.138a.
Повний текст джерелаLuder, Elisabeth. "Nutritional care of patients with cystic fibrosis." Topics in Clinical Nutrition 6, no. 2 (April 1991): 39–50. http://dx.doi.org/10.1097/00008486-199103000-00007.
Повний текст джерелаEisenblätter, J., K. Schlüter, F. Hellmond, A. Hofmann, and S. van Dullemen. "Nutrition cube: a nutrition counselling tool for patients with cystic fibrosis." Journal of Cystic Fibrosis 9 (June 2010): S89. http://dx.doi.org/10.1016/s1569-1993(10)60344-x.
Повний текст джерелаSchöni, M. H., and C. Casaulta-Aebischer. "Nutrition and lung function in cystic fibrosis patients: review." Clinical Nutrition 19, no. 2 (April 2000): 79–85. http://dx.doi.org/10.1054/clnu.1999.0080.
Повний текст джерелаДисертації з теми "Cystic fibrosis Patients Victoria Nutrition"
Durham, Dixie Lea. "Survey of adult cystic fibrosis patients and parents of cystic fibrosis patients on nutrition education." [Boise, Idaho] : Boise State University, 2009. http://scholarworks.boisestate.edu/td/8/.
Повний текст джерелаIsraelsen, Marlene. "Identification of Factors Affecting Susceptibility to Depression and Influencing Quality of Life in Adult Cystic Fibrosis Patients Based on Age-At-Diagnosis." DigitalCommons@USU, 2005. https://digitalcommons.usu.edu/etd/5525.
Повний текст джерелаRead, A. J. P. "The effect of Lactobacillus reuteri supplementation on anthropometric measurements, lung function and lung infections in a cystic fibrosis population in KwaZulu-Natal." Thesis, 2007. http://hdl.handle.net/10413/5281.
Повний текст джерелаColomba, Johann. "Anomalies de la tolérance au glucose chez les patients atteints de fibrose kystique Nouveaux facteurs de risque." Thesis, 2020. http://hdl.handle.net/1866/24587.
Повний текст джерелаIntroduction: Cystic fibrosis (CF) is a genetic disorder that affects several organs including the pancreas, liver, and lungs. It is expressed by an accumulation of viscous mucus which will cause an impairment of the functions of these organs. Scientific advances have improved the condition of life and significantly increased the life expectancy of patients with CF. This improved life expectancy of CF patients is associated with the onset of glucose tolerance abnormalities before the onset of CF-associated diabetes (CFRD). CFRD has similarities with type 1 diabetes [T1D] (low body weight, low insulin secretion) and type 2 diabetes [T2D] (glucose intolerance, abnormal insulin sensitivity), but it is specific for its causes and consequences. CFRD is associated with an increased risk of weight loss, reduced lung function and early mortality and affects 50% of adult patients. The main cause of this diabetes is described as a reduced and delayed insulin secretion. The risk factors leading to the development of CFRD and the consequences of its appearance are not well understood. The diet (rich in lipids and energy) recommended in CF, that aims at maintaining an adequate body weight, could be responsible for the accumulation of ectopic fat, insulin resistance, fatty liver and abnormalities of the lipid balance reported in FK. For patients without CF these anomalies are associated with the development of T2D. Objective: The aim of this thesis work was to identify new risk factors for abnormal glucose tolerance in a population of adults with CF. Method: For this we have i) observed the evolution of insulin secretion in elderly CF patients; ii) identified the association between liver enzymes and the prevalence of CFRD; iii) studied the prevalence of dyslipidemia in adult CF patients and the association with the risk of developing CFRD. Results: Our results have shown that adult CF patients have impaired insulin secretion, but it has not degraded further over a decade. However, over the same period, patients become more resistant to insulin. We have highlighted a relationship between the high alanine aminotransferase (ALT) enzyme level and the prevalence of CFRD. Finally, we have shown the existence of a high prevalence of dyslipidemia in CF but these anomalies are not associated with the occurrence of CFRD. Conclusion: This work has made possible to better understand the association between different risk factors linked to glucose tolerance abnormalities in adult CF patients. We have identified a mechanism and a possible biomarker, ALT hepatic enzyme, of CFRD in adult CF patients. These data may provide a relevant rationale for the pursuit of other clinical studies in order to improve the quality of life of patients with CF.
Книги з теми "Cystic fibrosis Patients Victoria Nutrition"
Horsley, Alex, Steve Cunningham, and J. Alastair Innes, eds. Cystic Fibrosis (Oxford Respiratory Medicine Library). Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780198702948.001.0001.
Повний текст джерелаGilchrist, Francis J., and Alex Horsley. Management of respiratory exacerbations. Oxford University Press, 2015. http://dx.doi.org/10.1093/med/9780198702948.003.0005.
Повний текст джерелаЧастини книг з теми "Cystic fibrosis Patients Victoria Nutrition"
Neuberger, James. "The liver in systemic disease." In Oxford Textbook of Medicine, edited by Jack Satsangi, 3169–78. Oxford University Press, 2020. http://dx.doi.org/10.1093/med/9780198746690.003.0331.
Повний текст джерела